Advertisement
Screener

GERON CORP (GERN) Operating Income

GERON CORP Operating Income

GERON CORP (GERN) reported Operating Income of -$12.50 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Income Statement

us-gaap:OperatingIncomeLoss · last filed 2026-08-05

  • GERON CORP operating income (loss) for the quarter ending 2026-06-30 was -$12.50M.
  • GERON CORP operating income (loss) for the quarter ending 2026-03-31 was $158.00K.
  • GERON CORP operating income (loss) for the quarter ending 2025-12-31 was -$25.54M.
  • GERON CORP operating income (loss) for the quarter ending 2025-09-30 was -$13.89M.
  • GERON CORP operating income (loss) for fiscal 2025 was -$68.58M.
  • GERON CORP operating income (loss) for fiscal 2024 was -$173.73M.
  • GERON CORP operating income (loss) for fiscal 2023 was -$193.94M.
  • GERON CORP operating income (loss) for fiscal 2022 was -$138.55M.
Period endOperating Income (Loss) 3 monthOperating Income (Loss) 6 monthOperating Income (Loss) 9 monthOperating Income (Loss) 12 month
2026-06-30-$12.50M
10-Q · filed 2026-08-05
-$12.34M
10-Q · filed 2026-08-05
-$37.88M
derived: sum of 3 quarters · filed 2026-08-05
-$51.77M
derived: sum of 4 quarters · filed 2026-08-05
2026-03-31$158.00K
10-Q · filed 2026-05-06
-$25.38M
derived: sum of 2 quarters · filed 2026-05-06
-$39.27M
derived: sum of 3 quarters · filed 2026-05-06
-$51.72M
derived: sum of 4 quarters · filed 2026-08-05
2025-12-31-$25.54M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02
-$39.43M
derived: sum of 2 quarters · filed 2026-03-02
-$51.88M
derived: sum of 3 quarters · filed 2026-08-05
-$68.58M
10-K · filed 2026-03-02
2025-09-30-$13.89M
10-Q · filed 2025-11-07
-$26.34M
derived: sum of 2 quarters · filed 2026-08-05
-$43.05M
10-Q · filed 2025-11-07
-$63.09M
derived: sum of 4 quarters · filed 2026-08-05
2025-06-30-$12.45M
10-Q · filed 2026-08-05
-$29.16M
10-Q · filed 2026-08-05
-$49.21M
derived: sum of 3 quarters · filed 2026-08-05
-$77.42M
derived: sum of 4 quarters · filed 2026-08-05
2025-03-31-$16.70M
10-Q · filed 2026-05-06
-$36.75M
derived: sum of 2 quarters · filed 2026-05-06
-$64.97M
derived: sum of 3 quarters · filed 2026-05-06
-$134.30M
derived: sum of 4 quarters · filed 2026-05-06
2024-12-31-$20.05M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02
-$48.27M
derived: sum of 2 quarters · filed 2026-03-02
-$117.60M
derived: sum of 3 quarters · filed 2026-03-02
-$173.73M
10-K · filed 2026-03-02
2024-09-30-$28.21M
10-Q · filed 2025-11-07
-$97.55M
derived: sum of 2 quarters · filed 2025-11-07
-$153.68M
10-Q · filed 2025-11-07
-$207.97M
derived: sum of 4 quarters · filed 2026-03-02
2024-06-30-$69.33M
10-Q · filed 2025-08-06
-$125.47M
10-Q · filed 2025-08-06
-$179.76M
derived: sum of 3 quarters · filed 2026-03-02
-$227.37M
derived: sum of 4 quarters · filed 2026-03-02
2024-03-31-$56.13M
10-Q · filed 2025-05-07
-$110.42M
derived: sum of 2 quarters · filed 2026-03-02
-$158.03M
derived: sum of 3 quarters · filed 2026-03-02
-$209.99M
derived: sum of 4 quarters · filed 2026-03-02
2023-12-31-$54.29M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02
-$101.90M
derived: sum of 2 quarters · filed 2026-03-02
-$153.85M
derived: sum of 3 quarters · filed 2026-03-02
-$193.94M
10-K · filed 2026-03-02
2023-09-30-$47.61M
10-Q · filed 2024-11-07
-$99.56M
derived: sum of 2 quarters · filed 2024-11-07
-$139.66M
10-Q · filed 2024-11-07
-$181.61M
derived: sum of 4 quarters · filed 2025-02-27
2023-06-30-$51.95M
10-Q · filed 2024-08-08
-$92.04M
10-Q · filed 2024-08-08
-$133.99M
derived: sum of 3 quarters · filed 2025-02-27
-$173.94M
derived: sum of 4 quarters · filed 2025-02-27
2023-03-31-$40.09M
10-Q · filed 2024-05-02
-$82.04M
derived: sum of 2 quarters · filed 2025-02-27
-$121.99M
derived: sum of 3 quarters · filed 2025-02-27
-$149.97M
derived: sum of 4 quarters · filed 2025-02-27
2022-12-31-$41.95M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27
-$81.90M
derived: sum of 2 quarters · filed 2025-02-27
-$109.88M
derived: sum of 3 quarters · filed 2025-02-27
-$138.55M
10-K · filed 2025-02-27
2022-09-30-$39.95M
10-Q · filed 2023-11-02
-$67.92M
derived: sum of 2 quarters · filed 2023-11-02
-$96.60M
10-Q · filed 2023-11-02
-$127.58M
derived: sum of 4 quarters · filed 2024-02-28
2022-06-30-$27.98M
10-Q · filed 2023-08-03
-$56.65M
10-Q · filed 2023-08-03
-$87.63M
derived: sum of 3 quarters · filed 2024-02-28
-$113.31M
derived: sum of 4 quarters · filed 2024-02-28
2022-03-31-$28.68M
10-Q · filed 2023-05-11
-$59.66M
derived: sum of 2 quarters · filed 2024-02-28
-$85.33M
derived: sum of 3 quarters · filed 2024-02-28
-$114.22M
derived: sum of 4 quarters · filed 2024-02-28
2021-12-31-$30.98M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28
-$56.66M
derived: sum of 2 quarters · filed 2024-02-28
-$85.55M
derived: sum of 3 quarters · filed 2024-02-28
-$114.00M
10-K · filed 2024-02-28
2021-09-30-$25.67M
10-Q · filed 2022-11-07
-$54.56M
derived: sum of 2 quarters · filed 2022-11-07
-$83.02M
10-Q · filed 2022-11-07
-$106.28M
derived: sum of 4 quarters · filed 2023-03-16
2021-06-30-$28.89M
10-Q · filed 2022-08-11
-$57.34M
10-Q · filed 2022-08-11
-$80.61M
derived: sum of 3 quarters · filed 2023-03-16
-$100.62M
derived: sum of 4 quarters · filed 2023-03-16
2021-03-31-$28.45M
10-Q · filed 2022-05-09
-$51.72M
derived: sum of 2 quarters · filed 2023-03-16
-$71.73M
derived: sum of 3 quarters · filed 2023-03-16
-$88.50M
derived: sum of 4 quarters · filed 2023-03-16
2020-12-31-$23.27M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16
-$43.28M
derived: sum of 2 quarters · filed 2023-03-16
-$60.04M
derived: sum of 3 quarters · filed 2023-03-16
-$76.91M
10-K · filed 2023-03-16
2020-09-30-$20.02M
10-Q · filed 2021-11-09
-$36.78M
derived: sum of 2 quarters · filed 2021-11-09
-$53.65M
10-Q · filed 2021-11-09
-$83.66M
derived: sum of 4 quarters · filed 2022-03-10
2020-06-30-$16.76M
10-Q · filed 2021-08-16
-$33.63M
10-Q · filed 2021-08-16
-$63.64M
derived: sum of 3 quarters · filed 2022-03-10
-$79.61M
derived: sum of 4 quarters · filed 2022-03-10
2020-03-31-$16.87M
10-Q · filed 2021-05-10
-$46.88M
derived: sum of 2 quarters · filed 2022-03-10
-$62.85M
derived: sum of 3 quarters · filed 2022-03-10
-$78.07M
derived: sum of 4 quarters · filed 2022-03-10
2019-12-31-$30.01M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10
-$45.98M
derived: sum of 2 quarters · filed 2022-03-10
-$61.20M
derived: sum of 3 quarters · filed 2022-03-10
-$72.50M
10-K · filed 2022-03-10
2019-09-30-$15.97M
10-Q · filed 2020-11-05
-$31.20M
derived: sum of 2 quarters · filed 2020-11-05
-$42.50M
10-Q · filed 2020-11-05
-$52.09M
derived: sum of 4 quarters · filed 2021-03-11
2019-06-30-$15.22M
10-Q · filed 2020-08-06
-$26.52M
10-Q · filed 2020-08-06
-$36.11M
derived: sum of 3 quarters · filed 2021-03-11
-$42.92M
derived: sum of 4 quarters · filed 2021-03-11
2019-03-31-$11.30M
10-Q · filed 2020-05-28
-$20.89M
derived: sum of 2 quarters · filed 2021-03-11
-$27.70M
derived: sum of 3 quarters · filed 2021-03-11
-$34.94M
derived: sum of 4 quarters · filed 2021-03-11
2018-12-31-$9.59M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11
-$16.39M
derived: sum of 2 quarters · filed 2021-03-11
-$23.64M
derived: sum of 3 quarters · filed 2021-03-11
-$31.07M
10-K · filed 2021-03-11
2018-09-30-$6.80M
10-Q · filed 2019-11-06
-$14.05M
derived: sum of 2 quarters · filed 2019-11-06
-$21.48M
10-Q · filed 2019-11-06
-$29.27M
derived: sum of 4 quarters · filed 2020-03-12
2018-06-30-$7.24M
10-Q · filed 2019-08-01
-$14.68M
10-Q · filed 2019-08-01
-$22.46M
derived: sum of 3 quarters · filed 2020-03-12
-$29.71M
derived: sum of 4 quarters · filed 2020-03-12
2018-03-31-$7.44M
10-Q · filed 2019-05-02
-$15.22M
derived: sum of 2 quarters · filed 2020-03-12
-$22.47M
derived: sum of 3 quarters · filed 2020-03-12
-$29.20M
derived: sum of 4 quarters · filed 2020-03-12
2017-12-31-$7.79M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12
-$15.03M
derived: sum of 2 quarters · filed 2020-03-12
-$21.76M
derived: sum of 3 quarters · filed 2020-03-12
-$29.25M
10-K · filed 2020-03-12
2017-09-30-$7.24M
10-Q · filed 2018-11-01
-$13.97M
derived: sum of 2 quarters · filed 2018-11-01
-$21.47M
10-Q · filed 2018-11-01
-$30.25M
derived: sum of 4 quarters · filed 2019-03-07
2017-06-30-$6.73M
10-Q · filed 2018-07-31
-$14.22M
10-Q · filed 2018-07-31
-$23.01M
derived: sum of 3 quarters · filed 2019-03-07
-$26.88M
derived: sum of 4 quarters · filed 2019-03-07
2017-03-31-$7.49M
10-Q · filed 2018-05-10
-$16.27M
derived: sum of 2 quarters · filed 2019-03-07
-$20.15M
derived: sum of 3 quarters · filed 2019-03-07
-$29.06M
derived: sum of 4 quarters · filed 2019-03-07
2016-12-31-$8.78M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07
-$12.66M
derived: sum of 2 quarters · filed 2019-03-07
-$21.57M
derived: sum of 3 quarters · filed 2019-03-07
-$30.65M
10-K · filed 2019-03-07
2016-09-30-$3.88M
10-Q · filed 2017-11-01
-$12.79M
derived: sum of 2 quarters · filed 2017-11-01
-$21.86M
10-Q · filed 2017-11-01
-$30.51M
derived: sum of 4 quarters · filed 2018-03-16
2016-06-30-$8.91M
10-Q · filed 2017-08-09
-$17.99M
10-Q · filed 2017-08-09
-$26.63M
derived: sum of 3 quarters · filed 2018-03-16
$388.00K
derived: sum of 4 quarters · filed 2018-03-16
2016-03-31-$9.08M
10-Q · filed 2017-05-09
-$17.72M
derived: sum of 2 quarters · filed 2018-03-16
$9.30M
derived: sum of 3 quarters · filed 2018-03-16
-$180.00K
derived: sum of 4 quarters · filed 2018-03-16
2015-12-31-$8.64M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16
$18.38M
derived: sum of 2 quarters · filed 2018-03-16
$8.90M
derived: sum of 3 quarters · filed 2018-03-16
-$559.00K
10-K · filed 2018-03-16
2015-09-30$27.02M
10-Q · filed 2016-11-03
$17.54M
derived: sum of 2 quarters · filed 2016-11-03
$8.09M
10-Q · filed 2016-11-03
-$926.00K
derived: sum of 4 quarters · filed 2017-03-01
2015-06-30-$9.48M
10-Q · filed 2016-08-03
-$18.93M
10-Q · filed 2016-08-03
-$27.95M
derived: sum of 3 quarters · filed 2017-03-01
-$37.85M
derived: sum of 4 quarters · filed 2017-03-01
2015-03-31-$9.46M
10-Q · filed 2016-05-05
-$18.47M
derived: sum of 2 quarters · filed 2017-03-01
-$28.37M
derived: sum of 3 quarters · filed 2017-03-01
-$37.04M
derived: sum of 4 quarters · filed 2017-03-01
2014-12-31-$9.01M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01
-$18.92M
derived: sum of 2 quarters · filed 2017-03-01
-$27.58M
derived: sum of 3 quarters · filed 2017-03-01
-$36.31M
10-K · filed 2017-03-01
2014-09-30-$9.91M
10-Q · filed 2015-11-05
-$18.57M
derived: sum of 2 quarters · filed 2015-11-05
-$27.30M
10-Q · filed 2015-11-05
-$36.58M
derived: sum of 4 quarters · filed 2016-03-10
2014-06-30-$8.66M
10-Q · filed 2015-08-05
-$17.39M
10-Q · filed 2015-08-05
-$26.67M
derived: sum of 3 quarters · filed 2016-03-10
-$35.40M
derived: sum of 4 quarters · filed 2016-03-10
2014-03-31-$8.73M
10-Q · filed 2015-05-07
-$18.01M
derived: sum of 2 quarters · filed 2016-03-10
-$26.74M
derived: sum of 3 quarters · filed 2016-03-10
-$35.70M
derived: sum of 4 quarters · filed 2016-03-10
2013-12-31-$9.28M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10
-$18.01M
derived: sum of 2 quarters · filed 2016-03-10
-$26.97M
derived: sum of 3 quarters · filed 2016-03-10
-$38.96M
10-K · filed 2016-03-10
2013-09-30-$8.73M
10-Q · filed 2014-11-05
-$17.70M
derived: sum of 2 quarters · filed 2014-11-05
-$29.68M
10-Q · filed 2014-11-05
-$48.17M
derived: sum of 4 quarters · filed 2015-03-11
2013-06-30-$8.96M
10-Q · filed 2014-08-11
-$20.95M
10-Q · filed 2014-08-11
-$39.43M
derived: sum of 3 quarters · filed 2015-03-11
-$55.31M
derived: sum of 4 quarters · filed 2015-03-11
2013-03-31-$11.98M
10-Q · filed 2014-05-01
-$30.47M
derived: sum of 2 quarters · filed 2015-03-11
-$46.35M
derived: sum of 3 quarters · filed 2015-03-11
-$64.83M
derived: sum of 4 quarters · filed 2015-03-11
2012-12-31-$18.48M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-11
-$34.36M
derived: sum of 2 quarters · filed 2015-03-11
-$52.84M
derived: sum of 3 quarters · filed 2015-03-11
-$71.76M
10-K · filed 2015-03-11
2012-09-30-$15.88M
10-Q · filed 2013-11-07
-$34.36M
derived: sum of 2 quarters · filed 2013-11-07
-$53.27M
10-Q · filed 2013-11-07
-$83.68M
derived: sum of 4 quarters · filed 2014-03-17
2012-06-30-$18.48M
10-Q · filed 2013-08-08
-$37.40M
10-Q · filed 2013-08-08
-$67.81M
derived: sum of 3 quarters · filed 2014-03-17
-$87.74M
derived: sum of 4 quarters · filed 2014-03-17
2012-03-31-$18.92M
10-Q · filed 2013-05-03
-$49.33M
derived: sum of 2 quarters · filed 2014-03-17
-$69.26M
derived: sum of 3 quarters · filed 2014-03-17
-$90.68M
derived: sum of 4 quarters · filed 2014-03-17
2011-12-31-$30.41M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17
-$50.34M
derived: sum of 2 quarters · filed 2014-03-17
-$71.76M
derived: sum of 3 quarters · filed 2014-03-17
-$96.12M
10-K · filed 2014-03-17
2011-09-30-$19.94M
10-Q · filed 2012-11-02
-$41.35M
derived: sum of 2 quarters · filed 2012-11-02
-$65.71M
10-Q · filed 2012-11-02
-$125.32M
derived: sum of 4 quarters · filed 2013-03-15
2011-06-30-$21.42M
10-Q · filed 2012-08-03
-$45.77M
10-Q · filed 2012-08-03
-$105.38M
derived: sum of 3 quarters · filed 2013-03-15
-$123.59M
derived: sum of 4 quarters · filed 2013-03-15
2011-03-31-$24.36M
10-Q · filed 2012-05-07
-$83.97M
derived: sum of 2 quarters · filed 2013-03-15
-$102.17M
derived: sum of 3 quarters · filed 2013-03-15
-$119.05M
derived: sum of 4 quarters · filed 2013-03-15
2010-12-31-$59.61M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15
-$77.81M
derived: sum of 2 quarters · filed 2013-03-15
-$94.69M
derived: sum of 3 quarters · filed 2013-03-15
-$111.17M
10-K · filed 2013-03-15
2010-09-30-$18.20M
10-Q · filed 2011-11-03
-$35.08M
derived: sum of 2 quarters · filed 2011-11-03
-$51.56M
10-Q · filed 2011-11-03
2010-06-30-$16.88M
10-Q · filed 2011-08-05
-$33.35M
10-Q · filed 2011-08-05
2009-12-31-$70.23M
10-K · filed 2012-03-07

Similar stocks

Stock NameCountryMarket CapPE Ratio
Aclaris Therapeutics, Inc. (ACRS)United States$0.792B-9.78
Olema Pharmaceuticals, Inc. (OLMA)United States$0.790B-5.35
GYRE THERAPEUTICS, INC. (GYRE)United States$0.818B-24.71
LEXICON PHARMACEUTICALS, INC. (LXRX)United States$0.823B-17.48
Wave Life Sciences, Inc. (WVE)$0.780B-5.56
Obsidian Therapeutics, Inc. (OBX)United States$0.829B
Immix Biopharma, Inc. (IMMX)United States$0.837B-18.44
Design Therapeutics, Inc. (DSGN)United States$0.766B-12.78
Avalo Therapeutics, Inc. (AVTX)United States$0.842B-9.74
Faeth Therapeutics, Inc. (FTH)United States$0.750B